MINDWALK HOLDINGS CORP
HYFTNASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- β
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 47.6M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $15M
- Last Q Revenue
- $4M
- P/E Ratio
- β
- P/S Ratio
- 2.9x
- EPS (TTM)
- β
- Dividend Yield
- β
- Dilution (1yr)
- +1.4%
MINDWALK HOLDINGS CORP
HYFTAbout MINDWALK HOLDINGS CORP
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.